BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20938034)

  • 1. Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis.
    Zhang Y; Metz LM
    Neurology; 2010 Oct; 75(15):1396. PubMed ID: 20938034
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
    J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.
    Dastgir J; DiMario FJ
    J Child Neurol; 2009 Apr; 24(4):431-7. PubMed ID: 19189932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
    Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
    Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute demyelinating disorder appearing as multiple cystic brain lesions.
    Kim P; McDougall A
    Arch Neurol; 2004 Jun; 61(6):966-7. PubMed ID: 15210542
    [No Abstract]   [Full Text] [Related]  

  • 7. Movement disorders in multiple sclerosis: Causal or coincidental association?
    Nociti V; Bentivoglio AR; Frisullo G; Fasano A; Soleti F; Iorio R; Loria G; Patanella AK; Marti A; Tartaglione T; Tonali PA; Batocchi AP
    Mult Scler; 2008 Nov; 14(9):1284-7. PubMed ID: 18768580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumefactive demyelinating lesion. Trying to find unity in diversity. Comparison of two cases.
    Adamek D; Radwanska E; Rog T; Grzywna E; Herman-Sucharska I
    Clin Neurol Neurosurg; 2014 Jan; 116():90-2. PubMed ID: 24269051
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epilepsy as the form of onset of multiple sclerosis with a pseudotumoural lesion].
    Jiménez-Caballero PE; Garrido-Robres JA
    Rev Neurol; 2002 Mar 16-31; 34(6):600. PubMed ID: 12040508
    [No Abstract]   [Full Text] [Related]  

  • 10. [Handicap lesions: recent contributions of imaging and neuropathology].
    Brochet B
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F131-7. PubMed ID: 18680831
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
    Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral demyelination in Wegener's granulomatosis.
    Brinar VV; Cikes N; Petelin Z; Hlavati M; Poser CM
    Clin Neurol Neurosurg; 2004 Jun; 106(3):233-6. PubMed ID: 15177774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of 53-years-old woman with the onset of subacute right-sided numbness, and presented with various lesions on MRI].
    Mizoi Y; Ida M; Takao M; Koto A; Orimo S; Inoue K; Yokochi M; Kawamura M; Takagi M; Fukuda T; Fujigasaki J
    No To Shinkei; 2005 Apr; 57(4):333-48. PubMed ID: 15948406
    [No Abstract]   [Full Text] [Related]  

  • 14. Open ring enhancement in atypical brain demyelination.
    Javalkar V; Manix M; Wilson J; Nanda A
    J Clin Neurosci; 2012 Jun; 19(6):910-2. PubMed ID: 22342238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism and multiple sclerosis--is there association?
    Barun B; Brinar VV; Zadro I; Lusić I; Radović D; Habek M
    Clin Neurol Neurosurg; 2008 Nov; 110(9):958-61. PubMed ID: 18482794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab.
    Moghadasi AN; Baghbanian SM
    Acta Neurol Belg; 2019 Mar; 119(1):137-139. PubMed ID: 29876751
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autopsy report of demyelinating myelitis with painful tonic seizures].
    Takahashi K; Nakamura H; Agari M; Yamasaki I
    Rinsho Shinkeigaku; 1976 Feb; 16(2):117-23. PubMed ID: 1033800
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute paraplegia with vanishing white matter lesions.
    Jensen RM; Kinkel RP
    Rev Neurol Dis; 2008; 5(3):159-60; discussion 164-6. PubMed ID: 18838956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.
    Filippi M; Falini A; Arnold DL; Fazekas F; Gonen O; Simon JH; Dousset V; Savoiardo M; Wolinsky JS;
    J Magn Reson Imaging; 2005 Jun; 21(6):669-75. PubMed ID: 15906322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent tumefactive demyelination in a child.
    Puri V; Chaudhry N; Gulati P; Tatke M; Singh D
    J Clin Neurosci; 2005 May; 12(4):495-500. PubMed ID: 15925795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.